Clinical Trial Update: A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of ramucirumab in combination therapy for advanced stomach cancer in Japanese participants; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stomach Neoplasms

Drugs mentioned

• Ramucirumab (ramucirumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Stomach Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2017-12-04